Q2 Earnings Forecast for Cronos Group Issued By Roth Capital

Cronos Group Inc. (NASDAQ:CRON) – Investment analysts at Roth Capital lowered their Q2 2025 EPS estimates for Cronos Group in a research note issued on Wednesday, November 13th. Roth Capital analyst W. Kirk now expects that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. The consensus estimate for Cronos Group’s current full-year earnings is ($0.05) per share. Roth Capital also issued estimates for Cronos Group’s FY2025 earnings at $0.00 EPS.

Cronos Group Price Performance

Shares of Cronos Group stock opened at $2.07 on Thursday. Cronos Group has a 1-year low of $1.85 and a 1-year high of $3.14. The stock has a market capitalization of $791.35 million, a PE ratio of -16.31 and a beta of 0.98. The company’s fifty day simple moving average is $2.17 and its 200-day simple moving average is $2.35.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. National Bank of Canada FI lifted its stake in shares of Cronos Group by 1,094.4% in the 2nd quarter. National Bank of Canada FI now owns 15,169 shares of the company’s stock valued at $35,000 after purchasing an additional 13,899 shares during the last quarter. Quantbot Technologies LP bought a new position in shares of Cronos Group in the 3rd quarter worth $37,000. Toronto Dominion Bank lifted its position in shares of Cronos Group by 204.8% during the first quarter. Toronto Dominion Bank now owns 17,054 shares of the company’s stock valued at $45,000 after buying an additional 11,459 shares during the last quarter. Cedar Wealth Management LLC acquired a new stake in Cronos Group in the first quarter valued at approximately $60,000. Finally, Headlands Technologies LLC boosted its position in shares of Cronos Group by 12,309.4% in the 2nd quarter. Headlands Technologies LLC now owns 27,797 shares of the company’s stock worth $65,000 after purchasing an additional 27,573 shares in the last quarter. Institutional investors own 8.71% of the company’s stock.

Cronos Group Company Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.